Mankind Pharma Ltd.

BSE: 543904 | NSE: MANKIND |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE634S01028 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Mankind Pharma Mankind Pharma Ltd. | BSE 2193.70 -0.55 (-0.03%) | NSE 2193.00 -0.30 (-0.01%) | Trade | Add

BSE Live

Dec 26, 16:01

2193.70 -0.55 (-0.03%)

Volume

AVERAGE VOLUME

5-Day

23,200

10-Day

23,982

30-Day

25,051

11,400

Prev. Close

2194.25
Open Price

2195.25

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 26, 15:55

2193.00 -0.30 (-0.01%)

Volume

AVERAGE VOLUME

5-Day

462,327

10-Day

559,087

30-Day

795,408

254,903

Prev. Close

2193.30
Open Price

2206.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2193.00 (238)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Mankind Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	9,497.80	9,263.66	8,120.57	7,240.86	5,486.16
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	9,497.80	9,263.66	8,120.57	7,240.86	5,486.16
Total Operating Revenues	9,497.80	9,264.81	8,127.15	7,257.04	5,529.60
Other Income	493.21	266.64	162.78	162.73	148.08
Total Revenue	9,991.01	9,531.45	8,289.94	7,419.77	5,677.68
EXPENSES
Cost Of Materials Consumed	800.43	861.74	711.05	772.24	494.53
Purchase Of Stock-In Trade	1,809.96	2,071.92	1,865.82	2,014.37	1,541.89
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-13.50	-25.36	267.89	-352.01	-254.25
Employee Benefit Expenses	2,131.67	1,982.10	1,701.38	1,443.83	1,106.14
Finance Costs	371.76	14.57	27.75	43.83	7.98
Depreciation And Amortisation Expenses	378.01	317.61	269.58	120.98	78.19
Other Expenses	2,190.87	2,049.30	1,883.64	1,578.99	1,263.00
Total Expenses	7,685.02	7,271.88	6,727.10	5,622.23	4,237.47
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,305.99	2,259.57	1,562.84	1,797.54	1,440.21
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	2,305.99	2,259.57	1,562.84	1,797.54	1,440.21
Tax Expenses-Continued Operations
Current Tax	469.93	416.56	296.00	399.58	344.89
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-48.19	19.60	30.30	49.09	8.84
Tax For Earlier Years	0.00	0.00	-11.72	13.74	2.10
Total Tax Expenses	421.74	436.16	314.58	462.41	355.83
Profit/Loss After Tax And Before ExtraOrdinary Items	1,884.25	1,823.41	1,248.26	1,335.13	1,084.37
Profit/Loss From Continuing Operations	1,884.25	1,823.41	1,248.26	1,335.13	1,084.37
Profit/Loss For The Period	1,945.48	1,823.41	1,248.26	1,335.13	1,084.37
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	48.16	45.52	31.16	33.33	27.07
Diluted EPS (Rs.)	48.07	45.45	31.16	33.33	27.07
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	0.00	0.00	0.00	0.00	0.00